P Sleight. Show Affiliations »
Abstract
Mesh: See more » Drug UtilizationEurope/epidemiologyFibrinolytic Agents/therapeutic useHumansMyocardial Infarction/complicationsMyocardial Infarction/drug therapyMyocardial Infarction/mortalityPatient SelectionPractice Patterns, Physicians'/statistics & numerical dataStreptokinase/therapeutic useStroke/etiologySurvival AnalysisThrombolytic Therapy/statistics & numerical dataTissue Plasminogen Activator/therapeutic useUnited States/epidemiology
Substances: See more » Fibrinolytic AgentsStreptokinaseTissue Plasminogen Activator
Year: 2001 PMID: 11345369 DOI: 10.1016/s0735-1097(01)01187-1
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094